<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref44">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dyall</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gross</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kindrachuk</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>R. F.</given-names>
   </name>
   <name>
    <surname>Olinger</surname>
    <given-names>G. G.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Hensley</surname>
    <given-names>L. E.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2017</year>). 
  <article-title>Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies</article-title>. 
  <source>Drugs</source>
  <volume>77</volume>, 
  <fpage>1935</fpage>â€“
  <lpage>1966</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s40265-017-0830-1</pub-id>, PMID: 
  <?supplied-pmid 29143192?>
  <pub-id pub-id-type="pmid">29143192</pub-id>
 </mixed-citation>
</ref>
